TardiMed Sciences LLC - 30 Aug 2022 Form 4 Insider Report for PaxMedica, Inc.

Role
10%+ Owner
Signature
/s/ Michael Derby, Managing Partner of TardiMed Sciences LLC
Issuer symbol
N/A
Transactions as of
30 Aug 2022
Net transactions value
+$498,750
Form type
4
Filing time
01 Sep 2022, 16:07:20 UTC
Previous filing
12 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PXMD Common Stock Purchase $498,750 +95,000 +1.3% $5.25* 7,336,745 30 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased from the underwriters by the reporting person in the issuer's initial public offering, which closed on August 30, 2022.